Ameriprise
IBB icon

Ameriprise’s iShares Biotechnology ETF IBB Stock Holding History

Ameriprise’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4M Sell
115,088
-488
-0.4% -$83.4K ﹤0.01% 1433
2025
Q4 		$19.5M Buy
115,576
+9,320
+9% +$1.51M ﹤0.01% 1433
2025
Q3 		$15.3M Buy
106,256
+2,112
+2% +$288K ﹤0.01% 1594
2025
Q2 		$13.2M Sell
104,144
-13,991
-12% -$1.72M ﹤0.01% 1613
2025
Q1 		$15.1M Sell
118,135
-34,026
-22% -$4.61M ﹤0.01% 1494
2024
Q4 		$20.1M Sell
152,161
-9,864
-6% -$1.39M 0.01% 1330
2024
Q3 		$23.6M Buy
162,025
+11,788
+8% +$1.71M 0.01% 1228
2024
Q2 		$20.6M Buy
150,237
+14,729
+11% +$1.97M 0.01% 1267
2024
Q1 		$18.5M Buy
135,508
+25,581
+23% +$3.49M 0.01% 1340
2023
Q4 		$14.9M Sell
109,927
-9,516
-8% -$1.16M ﹤0.01% 1452
2023
Q3 		$14.6M Sell
119,443
-26,345
-18% -$3.35M ﹤0.01% 1429
2023
Q2 		$18.5M Sell
145,788
-24,334
-14% -$3.16M 0.01% 1319
2023
Q1 		$21.3M Buy
170,122
+7,140
+4% +$935K 0.01% 1204
2022
Q4 		$21.4M Buy
162,982
+4,375
+3% +$565K 0.01% 1195
2022
Q3 		$19.2M Sell
158,607
-1,755
-1% -$218K 0.01% 1205
2022
Q2 		$18.9M Sell
160,362
-36,959
-19% -$4.39M 0.01% 1243
2022
Q1 		$25.7M Buy
197,321
+35,667
+22% +$4.65M 0.01% 1166
2021
Q4 		$24.7M Sell
161,654
-13,524
-8% -$2.09M 0.01% 1256
2021
Q3 		$28.3M Buy
175,178
+23,455
+15% +$3.95M 0.01% 1036
2021
Q2 		$24.9M Sell
151,723
-129,753
-46% -$20M 0.01% 1194
2021
Q1 		$42.5M Sell
281,476
-17,275
-6% -$2.74M 0.01% 843
2020
Q4 		$45.2M Buy
298,751
+8,484
+3% +$1.21M 0.02% 780
2020
Q3 		$39.2M Sell
290,267
-14,982
-5% -$2.03M 0.02% 735
2020
Q2 		$41.7M Buy
305,249
+186,539
+157% +$23.8M 0.02% 681
2020
Q1 		$13.4M Sell
118,710
-32,756
-22% -$3.77M 0.01% 1189
2019
Q4 		$18.3M Buy
151,466
+24,309
+19% +$2.71M 0.01% 1261
2019
Q3 		$13.2M Sell
127,157
-45,112
-26% -$4.72M 0.01% 1472
2019
Q2 		$18.8M Sell
172,269
-6,539
-4% -$696K 0.01% 1213
2019
Q1 		$20M Buy
178,808
+22,354
+14% +$2.45M 0.01% 1146
2018
Q4 		$15M Sell
156,454
-51,211
-25% -$5.44M 0.01% 1264
2018
Q3 		$25.3M Sell
207,665
-60,421
-23% -$7.11M 0.01% 1125
2018
Q2 		$29.1M Sell
268,086
-49,921
-16% -$5.34M 0.01% 936
2018
Q1 		$33.9M Buy
318,007
+1,279
+0.4% +$142K 0.02% 841
2017
Q4 		$34M Buy
316,728
+10,977
+4% +$1.17M 0.02% 747
2017
Q3 		$34M Buy
305,751
+26,001
+9% +$2.78M 0.02% 715
2017
Q2 		$29M Sell
279,750
-34,815
-11% -$3.43M 0.01% 785
2017
Q1 		$30.5M Buy
314,565
+84,864
+37% +$8.12M 0.02% 748
2016
Q4 		$20.3M Buy
229,701
+50,910
+28% +$4.63M 0.01% 989
2016
Q3 		$17.3M Sell
178,791
-43,614
-20% -$4.15M 0.01% 1027
2016
Q2 		$18.5M Sell
222,405
-44,178
-17% -$3.96M 0.01% 952
2016
Q1 		$23.2M Buy
266,583
+122,283
+85% +$10.9M 0.01% 827
2015
Q4 		$16.3M Buy
144,300
+15,102
+12% +$1.64M 0.01% 1069
2015
Q3 		$13.1M Sell
129,198
-44,583
-26% -$5.35M 0.01% 1243
2015
Q2 		$21.4M Buy
173,781
+26,418
+18% +$3.16M 0.01% 968
2015
Q1 		$16.9M Sell
147,363
-11,475
-7% -$1.27M 0.01% 1122
2014
Q4 		$16.1M Buy
158,838
+65,577
+70% +$6.37M 0.01% 1107
2014
Q3 		$8.51M Buy
93,261
+56,001
+150% +$4.91M 0.01% 1615
2014
Q2 		$3.19M Buy
37,260
+951
+3% +$74.9K ﹤0.01% 2320
2014
Q1 		$2.86M Buy
36,309
+3,243
+10% +$270K ﹤0.01% 2345
2013
Q4 		$2.5M Buy
33,066
+15,750
+91% +$1.12M ﹤0.01% 2374
2013
Q3 		$1.21M Sell
17,316
-2,430
-12% -$159K ﹤0.01% 2628
2013
Q2 		$1.15M Buy
+19,746
New +$1.14M ﹤0.01% 2563

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameriprise's IBB Position: Q1 2026 in Review

Ameriprise reduced its iShares Biotechnology ETF (IBB) stake by 0.42% in Q1 2026, selling an estimated $83.4K and leaving 115,088 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1433.

Ameriprise first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $45.2M in Q4 2020. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Ameriprise held 115,088 shares of iShares Biotechnology ETF worth $19.4M as of Q1 2026.
  • Ameriprise sold 488 iShares Biotechnology ETF shares in Q1 2026, an estimated $83.4K.
  • iShares Biotechnology ETF made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1433 holding.
  • Ameriprise first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's iShares Biotechnology ETF position peaked at $45.2M in Q4 2020.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.